NEWS
Akeso Biomedical has received a US patent covering some of its work to reduce the presence of the bacterium campylobacter in poultry using an antibiotic-free feed additive, says COO.
AUGUST 2017
Patent No. US 9,655,912 B2 titled “Reduction of Gastrointestinal Tract Colonization by Campylobacter”
AUGUST 2017
Akeso Biomedical™ Closes Financing Round of $4.4M
Funding for the Commercial Launch of Feed Additives for Poultry and Piglets to Combat Foodborne Illnesses and Improve Animal Microbiomes
JUNE 2017
Akeso's non-antibiotic feed additive targets Campylobacter in Europe
By Joseph Harvey, Animal Pharm News
JUNE 2017
A US start-up is launching its debut feed additive product designed to reduce the effect of harmful bacteria in the EU ahead of the US, as the US lags behind Europe in understanding and controlling campylobacter, says COO.
JUNE 2017
Akeso Biomedical™ Files TYPLEX™ Chelate Dossier to Reduce Campylobacter in EU Poultry
Significant reductions of enteropathogens in the GI tracts of broilers – by up to 3 log CFUs/gram in caeca
MAY 2017
Akeso Biomedical™ Appoints Scott Roth to its Board of Directors
Hedge fund manager to bring extensive financial expertise to the board.
FEBRUARY 2017
Akeso Biomedical Appoints Greg W. Lee to Board of Directors
Former president of Tyson Foods International to help commercialize food safety technology.
MARCH 2016
The Top 7 Boston-Area Startups to Watch in 2016
Akeso Biomedical is number four on list.
DECEMBER 2015
SEPTEMBER 2015
Banham Poultry and Akeso Biomedical Partner to Reduce Foodborne Illness due to Campylobacter
New class of feed additives promises unique solution to Campylobacter.
AUGUST 2015
Akeso Biomedical Enters into License Agreement for Fe3C Compounds to Prevent Foodborne Illness
New class of compounds promises solution to Campylobacter food poisoning.
MAY 2015
Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors
M.I.T. biotechnology professor to help expand Company’s technical portfolio and seek new solutions for treatment of bacterial infections and biofilms.
OCTOBER 2014
TOP OF PAGE